Globalization and Health

Papers
(The H4-Index of Globalization and Health is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Implementation and challenges to preventing the re-establishment of malaria in China in the COVID-19 era90
Comprehensive Medical Support in Complex Emergencies (CMSCE): pilot course review86
North Korea’s COVID-19 policy dilemma: epidemic prevention conflicting with trade70
Correction: Assessing the effects of mining projects on child health in sub-Saharan Africa: a multi-country analysis67
Cross-border utilization of cancer care by patients in the US and Mexico – a survey of Mexican oncologists64
Intellectual property licensing of therapeutics during the COVID-19 crisis: lessons learnt for pandemic preparedness and response59
National governance and excess mortality due to COVID-19 in 213 countries: a retrospective analysis and perspectives on future pandemics58
Constructing public–private partnerships to undermine the public interest: critical discourse analysis of Working Together published by the International Alliance for Responsible Drinking58
The alcohol industry’s involvement with road safety NGOs52
Analysing the impact of trade agreements on national food environments: the case of Vanuatu48
Capturing sources of health system legitimacy in fragmented conflict zones under different governance models: a case study of northwest Syria47
Rain, rain, go away, come again another day: do climate variations enhance the spread of COVID-19?46
Public health consequences after ten years of the Syrian crisis: a literature review45
Reserve antibiotics: overcoming limitations of evidence generated from regulatory approval trials42
Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region42
Lobbying and nutrition policy in Canada: a quantitative descriptive study on stakeholder interactions with government officials in the context of Health Canada’s Healthy Eating Strategy41
The politics of glyphosate regulation: lessons from Sri Lanka’s short-lived ban40
From isolation to revival: trade recovery amid global health crises40
Global smoking-related deaths averted due to MPOWER policies implemented at the highest level between 2007 and 202040
Learning from COVID-19: government leaders’ perspectives to improve emergency risk communication33
Universal coverage of the first antenatal care visit but poor continuity of care across the maternal and newborn health continuum among Nepalese women: analysis of levels and correlates33
Characteristics and outcomes of the drug patent linkage system in China33
Securing the rights and health of domestic workers: the importance of ratifying the ILO’s C18933
Food insecurity, COVID-19 and diets in Fiji – a cross-sectional survey of over 500 adults32
Who influences nutrition policy space using international trade and investment agreements? A global stakeholder analysis32
Financing of health services for undocumented immigrants in Iran: common challenges and potential solutions31
“We have to look deeper into why”: perspectives on problem identification and prioritization of women’s and girls’ health across United Nations agencies31
Vaccine nationalism will persist: global public goods need effective engagement of global citizens30
Future health expenditure in the BRICS countries: a forecasting analysis for 203530
De-escalation strategies for non-pharmaceutical interventions following infectious disease outbreaks: a rapid review and a proposed dynamic de-escalation framework29
0.06702995300293